Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
Tesla Is An AI Company That The Market Won’t Reward For Now
April 24, 2024
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
TMO Stock News and Mentions of Thermo Fisher Scientific Inc. Stocktwits
Updated: April 26, 2024 (09:55)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Thermo Fisher Scientific Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Thermo Fisher Scientific Inc. (TMO).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Thermo Fisher Scientific stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Thermo Fisher Scientific Inc. (TMO)
April 26, 2024 (16:45) / "Benzinga" (by Benzinga Insights)
Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity - Thermo Fisher Scientific ( NYSE:TMO )
Deep-pocketed investors have adopted a bearish approach towards Thermo Fisher Scientific TMO, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
In Article Trend: Somewhat-Bullish
April 25, 2024 (13:41) / "Zacks Commentary" (by Zacks Equity Research)
April 25, 2024 (13:14) / "Benzinga" (by Avi Kapoor)
These Analysts Revise Their Forecasts On Thermo Fisher Scientific Following Upbeat Earnings - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific Inc. TMO reported better-than-expected first-quarter financial results and raised its FY24 guidance on Wednesday. Thermo Fisher Scientific posted a first-quarter revenue of $10.34 billion, down 3% year over year, beating the consensus of $10.17 billion.
In Article Trend: Somewhat-Bullish
April 24, 2024 (18:15) / "Motley Fool" (by Motley Fool Transcribing)
Thermo Fisher Scientific ( TMO ) Q1 2024 Earnings Call Transcript
TMO earnings call for the period ending March 31, 2024.
In Article Trend: Somewhat-Bullish
April 24, 2024 (18:15) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher ( TMO ) Q1 Earnings Top Estimates, 2024 View Up
Thermo Fisher's (TMO) first-quarter 2024 revenues register year-over-year growth driven by new product launches.
In Article Trend: Neutral
April 24, 2024 (14:38) / "Benzinga" (by Vandana Singh)
Thermo Fisher Lifts Annual Forecast On Improved Demand, Despite Q1 Revenue Dip - Thermo Fisher Scientific ( NYSE:TMO )
On Wednesday, Thermo Fisher Scientific Inc. ( NYSE: TMO ) posted a first-quarter revenue of $10.34 billion, down 3% year over year, beating the consensus of $10.17 billion. Organic revenue was 4% lower, and core organic revenue growth declined by 3%.
In Article Trend: Somewhat-Bullish
April 24, 2024 (10:37) / "Benzinga" (by Shanthi Rexaline)
Nasdaq, S&P 500 To Open Higher After Tesla, TI Earnings: What's Driving Stock Futures? - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY )
Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. TSLA and semiconductor major Texas Instruments, Inc. TXN, although Dow futures were marginally lower.
In Article Trend: Neutral
April 23, 2024 (15:36) / "Zacks Commentary" (by Zacks Equity Research)
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
In Article Trend: Somewhat-Bullish
April 23, 2024 (12:00) / "PR Newswire" (by Congruence Therapeutics)
Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer
-Mr. Taffy joins from Schrödinger, bringing a wealth of relevant expertise to Congruence-
In Article Trend: Somewhat-Bullish
April 23, 2024 (12:00) / "Canada Newswire" (by Congruence Therapeutics)
Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer
-Mr. Taffy joins from Schrödinger, bringing a wealth of relevant expertise to Congruence-
In Article Trend: Somewhat-Bullish
April 22, 2024 (18:45) / "Benzinga" (by Benzinga Insights)
Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity - Thermo Fisher Scientific ( NYSE:TMO )
Deep-pocketed investors have adopted a bullish approach towards Thermo Fisher Scientific TMO, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
In Article Trend: Somewhat-Bullish
April 22, 2024 (14:40) / "Benzinga" (by Globe Newswire)
Food Safety Testing Market Size is projected to reach USD 36.76 billion by 2031, growing at a CAGR of 7.31%: Straits Research
New York, United States, April 22, 2024 ( GLOBE NEWSWIRE ) -- Food safety testing analyzes food products to identify and eliminate potential health risks. It examines food's chemical, physical, and microbiological properties, using various analytical techniques to ensure that food products are ...
In Article Trend: Somewhat-Bullish
April 22, 2024 (08:29) / "Barrons" (by Joe Woelfel)
Nvidia, Tesla, Super Micro, Verizon, Informatica, Coinbase, Cardinal Health, and More Stock Market Movers
Nvidia, Tesla, Super Micro, Salesforce, Verizon, and More Stock Market Movers ...
In Article Trend: Neutral
April 21, 2024 (21:45) / "Benzinga" (by Shanthi Rexaline)
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY )
As the market runs into rough weather, the importance of the upcoming week's earnings cannot be emphasized enough. A lot is riding on the earnings reports of companies like Tesla, Inc. TSLA, Meta Platforms, Inc. META, Microsoft Corp. MSFT and Alphabet, Inc. GOOGL ( GOOG ) .
In Article Trend: Neutral
April 19, 2024 (22:30) / "PR Newswire"
Lignocellulosic Feedstock-based Biofuel Market size is set to grow by USD 1.4 billion from 2023-2027, Aemetis Inc ... - PR Newswire
Lignocellulosic Feedstock-based Biofuel Market size is set to grow by USD 1.4 billion from 2023-2027, Aemetis Inc ... PR ...
In Article Trend: Somewhat-Bullish
April 19, 2024 (13:15) / "Zacks Commentary" (by Zacks Equity Research)
Seeking Clues to Thermo Fisher ( TMO ) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
In Article Trend: Neutral
April 18, 2024 (21:31) / "PR Newswire" (by DelveInsight Business Research)
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness.
In Article Trend: Neutral
April 18, 2024 (20:32) / "Benzinga" (by Benzinga Insights)
A Closer Look at Thermo Fisher Scientific's Options Market Dynamics - Thermo Fisher Scientific ( NYSE:TMO )
Financial giants have made a conspicuous bullish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific TMO revealed 10 unusual trades. Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies.
In Article Trend: Somewhat-Bullish
April 18, 2024 (15:40) / "Zacks Commentary" (by Zacks Equity Research)
TMO vs. IDXX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Thermo Fisher Scientific ( TMO Quick QuoteTMO - ) or Idexx Laboratories ( IDXX Quick QuoteIDXX - ) . But which of these two stocks offers value investors a better bang for their buck right now?
In Article Trend: Bullish
April 17, 2024 (14:30) / "Benzinga" (by Globe Newswire)
Blood Collection Market size worth $ 14.76 Billion, Globally, by 2031 at 5.10% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 17, 2024 ( GLOBE NEWSWIRE ) -- The Global Blood Collection Market is projected to grow at a CAGR of 5.10% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
April 17, 2024 (13:50) / "Benzinga" (by Globe Newswire)
Continuous Manufacturing Market Size is expected to reach USD 1,420.95 million by 2031, growing at a CAGR of 12.2%: Straits Research
New York, United States, April 17, 2024 ( GLOBE NEWSWIRE ) -- Continuous manufacturing is distinguished from batch manufacturing, which entails production execution in discrete steps separated by intervals by the uninterrupted feeding of raw materials into a manufacturing system and the ...
In Article Trend: Somewhat-Bullish
April 17, 2024 (12:30) / "Benzinga" (by Globe Newswire)
New to The Street and Banzai International, Inc. Sign 12-Month Media Contract - Banzai International ( NASDAQ:BNZI )
NEW YORK, April 17, 2024 ( GLOBE NEWSWIRE ) -- FMW Media Corp.'s New to The Street announces signing a twelve-month media contract with Banzai International, Inc. BNZI ( $BNZI ) ( "Banzai" ) .
In Article Trend: Somewhat-Bullish
April 16, 2024 (21:31) / "PR Newswire" (by LLP)
Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering market growth.
In Article Trend: Somewhat-Bullish
April 16, 2024 (14:56) / "Zacks Commentary" (by Zacks Equity Research)
Bio-Rad ( BIO ) Hurt by Softness in BioPharma and Competition
Bio-Rad's (BIO) margin performance bears the brunt of elevated raw material costs, increased logistics costs and higher employee-related expenses.
In Article Trend: Neutral
April 16, 2024 (13:00) / "PR Newswire"
Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO - PR Newswire
Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO PR ...
In Article Trend: Somewhat-Bullish
April 15, 2024 (16:58) / "Zacks Commentary" (by Zacks Equity Research)
What's in Store for Thermo Fisher ( TMO ) in Q1 Earnings?
Strength in Analytical Instrument and Laboratory Products and Services segments are likely to have driven Thermo Fisher's (TMO) first-quarter 2024 performance.
In Article Trend: Somewhat-Bullish
April 13, 2024 (03:33) / "PR Newswire" (by 360iResearch)
STD Testing Market Projected to Reach $14.11 billion by 2030 - Exclusive Report by 360iResearch
PUNE, India, April 12, 2024 /PRNewswire/ -- The report titled "STD Testing Market by Type ( Blood Tests, Lumbar Puncture, Swab Tests ) , Product Type ( Instruments, Reagents & Kits ) , Test Settings, Indication, End-user - Global Forecast 2024-2030" is now available on 360iResearch.com's ...
In Article Trend: Bullish
April 12, 2024 (20:31) / "Benzinga" (by Benzinga Insights)
A Closer Look at Thermo Fisher Scientific's Options Market Dynamics - Thermo Fisher Scientific ( NYSE:TMO )
Investors with significant funds have taken a bullish position in Thermo Fisher Scientific TMO, a development that retail traders should be aware of. This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga.
In Article Trend: Somewhat-Bullish
April 12, 2024 (13:10) / "Zacks Commentary" (by Zacks Equity Research)
Labcorp's ( LH ) At-Home Mpox Testing Kit Gets the FDA's EUA Nod
Labcorp (LH) receives the FDA's Emergency Use Authorization for the Mpox PCR Test Home Collection Kit.
In Article Trend: Neutral
April 11, 2024 (13:15) / "Zacks Commentary" (by Zacks Equity Research)
Waters ( WAT ) Boosts Waters Operating Segment With HPLC System
Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.
In Article Trend: Bullish
April 11, 2024 (13:10) / "Zacks Commentary" (by Zacks Equity Research)
Charles River ( CRL ) Forges Collaboration With Ship of Theseus
Charles River (CRL) is set to perform plasmid production for Ship of Theseus.
In Article Trend: Somewhat-Bullish
April 10, 2024 (16:00) / "Benzinga" (by Benzinga Insights)
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific TMO has outperformed the market over the past 10 years by 6.41% on an annualized basis producing an average annual return of 17.2%. Currently, Thermo Fisher Scientific has a market capitalization of $221.16 billion.
In Article Trend: Somewhat-Bullish
April 9, 2024 (21:41) / "PR Newswire" (by DelveInsight Business Research)
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding elderly population susceptible to such ailments, and the potential breakthroughs in treating cancers, blood disorders, immune conditions, ...
In Article Trend: Somewhat-Bullish
April 9, 2024 (12:34) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher ( TMO ) Launches TSX Universal Series ULT Freezers
Thermo Fisher's (TMO) new ENERGY STAR-certified TSX Universal Series ULT Freezers deliver tighter temperature control and faster recovery times.
In Article Trend: Somewhat-Bullish
April 8, 2024 (15:45) / "Benzinga" (by Benzinga Insights)
( TMO ) - Analyzing Thermo Fisher Scientific's Short Interest - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific's TMO short percent of float has risen 16.88% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 0.9% of all regular shares that are available for trading.
In Article Trend: Somewhat-Bullish
April 8, 2024 (13:00) / "PR Newswire"
Clario appoints Julia James as Chief Legal and Administrative Officer USA - English - USA - English - PR Newswire
Clario appoints Julia James as Chief Legal and Administrative Officer USA - English - USA - English PR ...
In Article Trend: Bullish
April 5, 2024 (22:02) / "PR Newswire"
Genome Editing Market size is set to grow by USD 7.23 bn from 2024-2028,rapid technological advancements in ... - PR Newswire
Genome Editing Market size is set to grow by USD 7.23 bn from 2024-2028,rapid technological advancements in ... PR ...
In Article Trend: Neutral
April 5, 2024 (22:00) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific ( TMO ) Outpaces Stock Market Gains: What You Should Know
Thermo Fisher Scientific (TMO) closed the most recent trading day at $579.46, moving +1.55% from the previous trading session.
In Article Trend: Somewhat-Bullish
April 5, 2024 (14:30) / "PR Newswire" (by MarketsandMarkets)
Companion Diagnostics Market Worth $13.6 billion | MarketsandMarkets™
CHICAGO, April 5, 2024 /PRNewswire/ -- Companion Diagnostics Market in terms of revenue was estimated to be worth $7.5 billion in 2024 and is poised to reach $13.6 billion by 2029, growing at a CAGR of 12.6% from 2024 to 2029 according to a new report by MarketsandMarkets™.
In Article Trend: Somewhat-Bullish
April 5, 2024 (12:00) / "GlobeNewswire" (by Akoya Biosciences)
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
MARLBOROUGH, Mass., April 05, 2024 ( GLOBE NEWSWIRE ) -- Akoya Biosciences, Inc., ( Nasdaq: AKYA ) , The Spatial Biology Company®, today announced it will highlight case studies featuring its Spatial Biology 2.0 Solutions that enable unprecedented speed and scale for spatial biology studies at ...
In Article Trend: Neutral
April 5, 2024 (12:00) / "Benzinga" (by Globe Newswire)
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale - Akoya Biosciences ( NASDAQ:AKYA )
MARLBOROUGH, Mass., April 05, 2024 ( GLOBE NEWSWIRE ) -- Akoya Biosciences, Inc., AKYA, The Spatial Biology Company®, today announced it will highlight case studies featuring its Spatial Biology 2.0 Solutions that enable unprecedented speed and scale for spatial biology studies at the American ...
In Article Trend: Neutral
April 5, 2024 (10:01) / "PR Newswire"
Single-use Bioprocessing System Market size is set to grow by USD 15.32 bn from 2024-2028,high demand for ... - PR Newswire
Single-use Bioprocessing System Market size is set to grow by USD 15.32 bn from 2024-2028,high demand for ... PR ...
In Article Trend: Somewhat-Bullish
April 4, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific Inc. ( TMO ) is Attracting Investor Attention: Here is What You Should Know
Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In Article Trend: Somewhat-Bullish
April 4, 2024 (12:53) / "Benzinga" (by Avi Kapoor)
Thermo Fisher Scientific, GXO Logistics And A Financial Stock On CNBC's 'Final Trades' - Nasdaq ( NASDAQ:NDAQ ) , GXO Logistics ( NYSE:GXO )
On CNBC's "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners picked GXO Logistics, Inc. GXO, saying they do well each quarter. On Feb. 13, GXO Logistics posted better-than-expected results for its fourth quarter.
In Article Trend: Somewhat-Bullish
April 3, 2024 (12:00) / "Benzinga" (by PRNewswire)
PixCell Medical Partners with Healthcare Giants Medline, Henry Schein, and Fisher Scientific to Distribute HemoScreen Point of Care CBC Analyzer Across the USA
YOKNEAM ILIT, Israel, April 3, 2024 /PRNewswire/ -- PixCell Medical, a leading provider of innovative point-of-care diagnostic solutions, is pleased to announce a strategic distribution partnership with Medline, adding to the partnership agreements with Henry Schein and Thermo Fisher Scientific ...
In Article Trend: Bullish
April 2, 2024 (22:15) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific ( TMO ) Dips More Than Broader Market: What You Should Know
Thermo Fisher Scientific (TMO) reachead $571.56 at the closing of the latest trading day, reflecting a -1.02% change compared to its last close.
In Article Trend: Neutral
April 2, 2024 (15:30) / "Benzinga" (by Globe Newswire)
Exponential Growth Predicted For Genotyping Assay Market: Rising Demand For Personalized Medicine To Fuel Growth As Per The Business Research Company's Genotyping Assay Global Market Report 2024
LONDON, April 02, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Genotyping Assay Global Market Report 2024, the global genotyping assay market has experienced exponential growth in recent years, driven by factors such as customization and personalization trends, rising demand ...
In Article Trend: Bullish
April 2, 2024 (12:36) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher ( TMO ) Debuts a New In-Line Metrology Solution
Thermo Fisher's (TMO) new LInspector Edge In-line Mass Profilometer delivers real-time, full-coverage mass loading analysis for battery electrode coating.
In Article Trend: Somewhat-Bullish
April 1, 2024 (14:31) / "Benzinga" (by Benzinga Insights)
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific TMO has outperformed the market over the past 5 years by 3.13% on an annualized basis producing an average annual return of 15.79%. Currently, Thermo Fisher Scientific has a market capitalization of $219.46 billion.
In Article Trend: Somewhat-Bullish
March 30, 2024 (01:45) / "PR Newswire" (by Research and Markets)
DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates
DUBLIN, March 29, 2024 /PRNewswire/ -- The "Global DNA Methylation Detection Technology Market: Focus on Technology, Application, End User, Product Type, Country Level Analysis and Competitive Landscape - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
In Article Trend: Somewhat-Bullish
March 29, 2024 (22:15) / "PR Newswire" (by Research and Markets)
Mesenchymal Stem Cells / Medicinal Signaling Cells ( MSCs ) Advancements & Future Forecasts through 2030
DUBLIN, March 29, 2024 /PRNewswire/ -- The "Mesenchymal Stem Cells / Medicinal Signaling Cells ( MSCs ) - Advances & Applications, 2023" report has been added to ResearchAndMarkets.com's offering.
In Article Trend: Somewhat-Bullish
March 29, 2024 (16:15) / "PR Newswire" (by Research and Markets)
Global Automated Liquid Handling Systems Market Outlook & Forecasts 2023-2024 & 2029: AI Integration and Tech Advancements Spur Innovation, Complexity in Lab Procedures and Demand for Miniaturization
Global Automated Liquid Handling Systems Market Outlook & Forecasts 2023-2024 & 2029: AI Integration and Tech ... PR ...
In Article Trend: Neutral
March 29, 2024 (10:30) / "PR Newswire" (by Research and Markets)
Global Sample Preparation Market Analysis and Outlook 2023-2030 Featuring Profiles of Agilent Technologies, Bio-Rad Labs, Danaher Corp, Illumina, Merck, and Other Key Players
Global Sample Preparation Market Analysis and Outlook 2023-2030 Featuring Profiles of Agilent Technologies, Bio ... PR ...
In Article Trend: Somewhat-Bullish
March 29, 2024 (05:00) / "Barrons" (by Connor Smith)
Synopsys Director Makes Rare Insider Purchase
Artificial-intelligence enthusiasm has given Synopsys shares a boost this year. A director recently made a rare insider purchase. Synopsys stock has rallied nearly 11% this year, outpacing both the Nasdaq Composite and the S&P 500 index.
In Article Trend: Somewhat-Bullish
March 28, 2024 (12:01) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why Investors Should Retain Thermo Fisher ( TMO ) Stock
Strength in end markets and strategic collaborations bode well for Thermo Fisher (TMO).
In Article Trend: Somewhat-Bullish
March 27, 2024 (22:00) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific ( TMO ) Exceeds Market Returns: Some Facts to Consider
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $579.37, denoting a +1.85% change from the preceding trading day.
In Article Trend: Somewhat-Bullish
March 27, 2024 (13:30) / "Benzinga" (by Globe Newswire)
Food Diagnostics Market Size, Share, Growth Drivers, Segmentation, and Leading Players
Chicago, March 27, 2024 ( GLOBE NEWSWIRE ) -- The Food Diagnostics Market refers to the industry involved in the development, production, and distribution of diagnostic tools and technologies used in the food industry.
In Article Trend: Bullish
March 26, 2024 (22:15) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific ( TMO ) Falls More Steeply Than Broader Market: What Investors Need to Know
Thermo Fisher Scientific (TMO) concluded the recent trading session at $568.82, signifying a -0.83% move from its prior day's close.
In Article Trend: Somewhat-Bullish
March 26, 2024 (06:15) / "GlobeNewswire" (by Tecan Group AG)
Annual General Meeting 2024: Tecan proposes election of an additional member of the Board of Directors and various amendments to the Articles of Incorporation
Annual General Meeting 2024: Tecan proposes election of an additional member of the Board of Directors and various amendments to the Articles of Incorporation • Monica Manotas proposed as a new member of the Board of Directors • Board of Directors will propose all current members for re-election ...
In Article Trend: Somewhat-Bullish
March 25, 2024 (14:05) / "Zacks Commentary" (by Zacks Equity Research)
Bayer ( BAYRY ) Banks on Pipeline Progress Amid Challenges
Bayer (BAYRY) relies on pipeline candidate elinzanetant and key drugs, Nubeqa and Kerendia, to drive growth amid pipeline and regulatory setbacks.
In Article Trend: Neutral
March 25, 2024 (13:10) / "Zacks Commentary" (by Zacks Equity Research)
QIAGEN ( QGEN ) Partners With IPPA to Raise TB Screening Awareness
QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.
In Article Trend: Somewhat-Bullish
March 25, 2024 (12:50) / "Zacks Commentary" (by Zacks Equity Research)
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
In Article Trend: Somewhat-Bullish
March 22, 2024 (13:41) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher ( TMO ) Inks Deal to Develop Companion Diagnostics
Thermo Fisher's (TMO) new partnership with Bayer AG is likely to help increase the latter's precision cancer therapies.
In Article Trend: Somewhat-Bullish
March 22, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Point of Care Diagnostics Market is Expected to Reach $77.8 billion | MarketsandMarkets™
Chicago, March 22, 2024 ( GLOBE NEWSWIRE ) -- Point of Care Diagnostics market in terms of revenue was estimated to be worth $49.7 billion in 2023 and is poised to reach $77.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028 according to a latest report published by ...
In Article Trend: Somewhat-Bullish
March 21, 2024 (18:02) / "Benzinga" (by Benzinga Insights)
A Closer Look at Thermo Fisher Scientific's Options Market Dynamics - Thermo Fisher Scientific ( NYSE:TMO )
Deep-pocketed investors have adopted a bullish approach towards Thermo Fisher Scientific TMO, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
In Article Trend: Somewhat-Bullish
March 20, 2024 (22:00) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific ( TMO ) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $580.05, denoting a -0.46% change from the preceding trading day.
In Article Trend: Somewhat-Bullish
March 20, 2024 (12:00) / "Investors Business Daily" (by MATT KRANTZ)
Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss
Eli Lilly's Mounjaro and Novo Nordisk's Ozempic and Wegovy are headliners in the expected boom in GLP-1 weight-loss drugs. But investors are making even more money on tangential players.
In Article Trend: Somewhat-Bullish
March 20, 2024 (09:48) / "Zacks Commentary" (by Zacks Investment Research)
The Zacks Analyst Blog Highlights Mastercard, AbbVie, Salesforce, Thermo Fisher Scientific and Mondelez
Mastercard, AbbVie, Salesforce, Thermo Fisher Scientific and Mondelez are included in this Analyst Blog.
In Article Trend: Somewhat-Bullish
March 19, 2024 (12:30) / "PR Newswire" (by Flagship Pioneering)
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Ranked #3 Most Innovative Company in North America Recognized for the Third Consecutive Year CAMBRIDGE, Mass., March 19, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, has been named to Fast Company's prestigious list of the World's Most Innovative Companies of ...
In Article Trend: Bullish
March 19, 2024 (11:30) / "GlobeNewswire" (by Repligen Corporation)
Repligen Appoints Maggie A. Pax to Board of Directors
WALTHAM, Mass., March 19, 2024 ( GLOBE NEWSWIRE ) -- Repligen Corporation ( NASDAQ:RGEN ) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax. This appointment expands the size of Repligen's board from eight to nine members.
In Article Trend: Somewhat-Bullish
March 19, 2024 (11:30) / "Benzinga" (by Globe Newswire)
Repligen Appoints Maggie A. Pax to Board of Directors - Repligen ( NASDAQ:RGEN )
WALTHAM, Mass., March 19, 2024 ( GLOBE NEWSWIRE ) -- Repligen Corporation RGEN today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax. This appointment expands the size of Repligen's board from eight to nine members.
In Article Trend: Somewhat-Bullish
March 18, 2024 (22:15) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific ( TMO ) Stock Falls Amid Market Uptick: What Investors Need to Know
Thermo Fisher Scientific (TMO) reachead $580.05 at the closing of the latest trading day, reflecting a -0.7% change compared to its last close.
In Article Trend: Somewhat-Bullish
March 18, 2024 (14:08) / "Business Insider" (by Benzinga Insights)
4 Analysts Assess Thermo Fisher Scientific: What You Need To Know
4 analysts have expressed a variety of opinions on Thermo Fisher Scientific ( NYSE:TMO ) over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares ...
In Article Trend: Somewhat-Bullish
March 18, 2024 (13:41) / "Benzinga" (by Globe Newswire)
Multiplex Assays Market on Track to Surpass USD 5.9 Billion by 2031 at a moderate CAGR of 6.9% | Analysis by Transparency Market Research, Inc.
Wilmington, Delaware, United States, March 18, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global multiplex assays market is estimated to be valued at US$ 5.9 billion by 2031. As of 2022, the market valuation turned out to be US$ 3.2 billion.
In Article Trend: Somewhat-Bullish
March 14, 2024 (17:30) / "Benzinga" (by Benzinga Insights)
Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific TMO has outperformed the market over the past 15 years by 7.51% on an annualized basis producing an average annual return of 21.03%. Currently, Thermo Fisher Scientific has a market capitalization of $226.24 billion.
In Article Trend: Somewhat-Bullish
March 14, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific Inc. ( TMO ) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Thermo Fisher (TMO). This makes it worthwhile to examine what the stock has in store.
In Article Trend: Somewhat-Bullish
March 13, 2024 (01:30) / "GlobeNewswire" (by Inc.)
High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization
$250,000 top award goes to Achyuta Rajaram in the nation's oldest and most prestigious Science, Technology, Engineering and Math ( STEM ) competition for high school seniors $250,000 top award goes to Achyuta Rajaram in the nation's oldest and most prestigious Science, Technology, Engineering ...
In Article Trend: Bullish
March 12, 2024 (22:00) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific ( TMO ) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $597.25, marking a -0.36% move from the previous day.
In Article Trend: Somewhat-Bullish
March 12, 2024 (16:30) / "Forbes" (by PhD)
50 Top Jobs To Consider When Making A Career Change
If you're considering a career change, it's a great time to make a move, and there are certain jobs and fields which will be especially flush with opportunity - no matter why you want to make a shift.
In Article Trend: Somewhat-Bullish
March 12, 2024 (12:27) / "Zacks Commentary" (by Zacks Equity Research)
Bio-Rad ( BIO ) Suffers due to BioPharma Softness, Stiff Competition
Bio-Rad's (BIO) margin performance gets affected by the inflationary trend of elevated raw material costs, increased logistics costs and higher employee-related expenses.
In Article Trend: Neutral
March 12, 2024 (02:30) / "PR Newswire" (by Research and Markets)
Japan In-Vitro Diagnostics Market Analysis Report 2024-2030: Strategic Partnerships Drive Innovations, Tumor Marker Testing Gains Momentum
Japan In-Vitro Diagnostics Market Analysis Report 2024-2030: Strategic Partnerships Drive Innovations, Tumor Marker ... PR ...
In Article Trend: Somewhat-Bullish
March 11, 2024 (14:20) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher ( TMO ) Unveils CorEvitas Clinical Registry in GPP
Thermo Fisher's (TMO) new CorEvitas clinical registry addresses an unmet need for real-world evidence related to the clinical and patient-reported outcomes of patients with GPP.
In Article Trend: Somewhat-Bullish
March 11, 2024 (11:00) / "Benzinga" (by Globe Newswire)
Autolus Therapeutics announces publication in Blood Cancer Journal - Autolus Therapeutics ( NASDAQ:AUTL )
LONDON, March 11, 2024 ( GLOBE NEWSWIRE ) -- Autolus Therapeutics plc AUTL, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced a publication in Blood Cancer Journal entitled 'Dual T-cell constant β chain ( TRBC ) 1 and TRBC2 ...
In Article Trend: Neutral
March 11, 2024 (09:22) / "Benzinga" (by Globe Newswire)
Al in Omics Studies Market Worth USD 5.44 Billion to 2031 - Exclusive Report by InsightAce Analytic
Jersey City, NJ, March 11, 2024 ( GLOBE NEWSWIRE ) -- InsightAce Analytic Pvt.
In Article Trend: Somewhat-Bullish
March 8, 2024 (22:48) / "PR Newswire"
Protein Expression Market size to grow by USD 2.45 billion from 2023 to 2027, North America accounts for 37% of ... - PR Newswire
Protein Expression Market size to grow by USD 2.45 billion from 2023 to 2027, North America accounts for 37% of ... PR ...
In Article Trend: Somewhat-Bullish
March 8, 2024 (16:30) / "Zacks Commentary" (by Zacks Equity Research)
Why Is Steris ( STE ) Up 5.8% Since Last Earnings Report?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 8, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
Why Is Steris ( STE ) Up 5.8% Since Last Earnings Report?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 7, 2024 (16:31) / "Zacks Commentary" (by Zacks Equity Research)
Edwards Lifesciences ( EW ) Up 2% Since Last Earnings Report: Can It Continue?
Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Somewhat-Bullish
March 7, 2024 (13:25) / "Benzinga" (by Globe Newswire)
Banzai Expands Reach Solution - Banzai International ( NASDAQ:BNZI )
SEATTLE, March 07, 2024 ( GLOBE NEWSWIRE ) -- Banzai International, Inc. BNZI, a leading marketing technology company that provides essential marketing and sales solutions, today announced an expansion of Reach, its event marketing solution.
In Article Trend: Bullish
March 7, 2024 (13:25) / "GlobeNewswire" (by Inc.)
Banzai Expands Reach Solution
Banzai today announced an expansion of Reach, its event marketing solution.
In Article Trend: Somewhat-Bullish
March 7, 2024 (09:59) / "Benzinga" (by Globe Newswire)
Stem Cell Manufacturing Market Worth USD 26.6 billion, Growing At 9.2% CAGR by 2033 - Report By Transparency Market Research, Inc.
Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global stem cell manufacturing market is estimated to flourish at a CAGR of 9.2% from 2023 to 2033.
In Article Trend: Bullish
March 7, 2024 (09:43) / "Benzinga" (by Globe Newswire)
Medical Membrane Market Size & Share to Surpass USD 10.2 billion by 2031 | Analysis by Transparency Market Research, Inc.
Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global landscape of the medical membrane market promises to flourish with a CAGR of 9.2% by the end of 2031.
In Article Trend: Somewhat-Bullish
March 7, 2024 (07:31) / "Benzinga" (by Globe Newswire)
Biomarkers Market to Reach USD 125.6 billion by 2031, Projected a CAGR of 10.4%: Report Analysis by Transparency Market Research, Inc.
Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global biomarkers market is estimated to flourish at a CAGR of 10.4% from 2023 to 2031.
In Article Trend: Somewhat-Bullish
March 6, 2024 (23:00) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific ( TMO ) Exceeds Market Returns: Some Facts to Consider
Thermo Fisher Scientific (TMO) reachead $591.50 at the closing of the latest trading day, reflecting a +1.18% change compared to its last close.
In Article Trend: Somewhat-Bullish
March 6, 2024 (19:45) / "Investors Business Daily" (by JAMES DETAR)
Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months
Thermo Fisher Stock Soars 40% In 5 Months Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
March 6, 2024 (16:30) / "Zacks Commentary" (by Zacks Equity Research)
Idexx ( IDXX ) Down 1.5% Since Last Earnings Report: Can It Rebound?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Somewhat-Bullish
March 6, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
IBD Rating Upgrades: Thermo Fisher Scientific Shows Improved Price Strength
In a welcome move, Thermo Fisher Scientific ( TMO ) saw its Relative Strength Rating improve from 69 to 73 on Wednesday. X IBD's proprietary RS Rating measures market leadership by using a 1 ( worst ) to 99 ( best ) score that identifies how a stock's price action over the trailing 52 weeks ...
In Article Trend: Somewhat-Bullish
March 5, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Real World Evidence Solutions Market is Expected to Reach $4.5 Billion | MarketsandMarkets™
Chicago, March 05, 2024 ( GLOBE NEWSWIRE ) -- Real World Evidence Solutions market in terms of revenue was estimated to be worth $2.0 billion in 2024 and is poised to reach $4.5 billion by 2029, growing at a CAGR of 16.5% from 2024 to 2029 according to a latest report published by ...
In Article Trend: Somewhat-Bullish
March 2, 2024 (00:48) / "PR Newswire"
Biopharmaceutical Analytical Testing Services Market size to grow by USD 3.45 billion from 2022 to 2027, North ... - PR Newswire
Biopharmaceutical Analytical Testing Services Market size to grow by USD 3.45 billion from 2022 to 2027, North ... PR ...
In Article Trend: Somewhat-Bullish
March 1, 2024 (16:30) / "Zacks Commentary" (by Zacks Equity Research)
Why Is Thermo Fisher ( TMO ) Up 3.3% Since Last Earnings Report?
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 1, 2024 (14:00) / "Zacks Commentary" (by Zacks Equity Research)
Investors Heavily Search Thermo Fisher Scientific Inc. ( TMO ) : Here is What You Need to Know
Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In Article Trend: Somewhat-Bullish
March 1, 2024 (06:43) / "Benzinga" (by Globe Newswire)
Lipid Nanoparticles ( LNPs ) CDMO Market Players are mainly Focusing on the Nucleic Acids LNPs - Here's Why | 2024 Exclusive InsightAce Report
Jersey City, NJ, March 01, 2024 ( GLOBE NEWSWIRE ) -- "The Lipid Nanoparticles ( LNPs ) CDMO Market" in terms of revenue was estimated to be worth $182.0 Mn in 2023 and is poised to reach $518.2 Mn by 2031, growing at a CAGR of 14.10% from 2024 to 2031 according to a new report by Insight Ace ...
In Article Trend: Somewhat-Bullish
March 1, 2024 (06:32) / "Benzinga" (by Globe Newswire)
Biopharmaceutical Fermentation Systems Market Projected to Reach USD 52.6 billion by 2031, with a CAGR of 9.5%: Report by Transparency Market Research Inc.
Wilmington, Delaware, United States, March 01, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global biopharmaceutical fermentation systems market is projected to grow at a CAGR of 9.5% from 2023 to 2031.
In Article Trend: Somewhat-Bullish
March 1, 2024 (03:31) / "PR Newswire" (by Thermo Fisher Scientific)
Thermo Fisher Scientific to Inaugurate New Office, Marking Milestone Expansion in Indonesia
Company to support advancements in country's science and technology sector, with a focus on progressing healthcare, environmental solutions, and food safety
In Article Trend: Bullish
March 1, 2024 (00:36) / "PR Newswire"
Cannabis Testing Market size to grow by USD 1.50 billion from 2022-2027, AB SCIEX LLC, Agilent Technologies Inc ... - PR Newswire
Cannabis Testing Market size to grow by USD 1.50 billion from 2022-2027, AB SCIEX LLC, Agilent Technologies Inc ... PR ...
In Article Trend: Somewhat-Bullish
February 29, 2024 (23:00) / "Zacks Commentary" (by Zacks Equity Research)
Thermo Fisher Scientific ( TMO ) Stock Sinks As Market Gains: What You Should Know
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $570.18, denoting a -0.32% change from the preceding trading day.
In Article Trend: Somewhat-Bullish
February 29, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Transfection Technologies Market is Expected to Reach $1.8 Billion | MarketsandMarkets™
Chicago, Feb. 29, 2024 ( GLOBE NEWSWIRE ) -- Transfection Technologies market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $1.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.
In Article Trend: Somewhat-Bullish
February 29, 2024 (07:12) / "Investing News Network" (by Investing News Network)
Appendix 4D and Half Yearly Accounts
Thermo Fisher Scientific Inc. ( NYSE: TMO ) , the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen Health Care Conference on Wednesday, March 6, 2024 at 9:10 a.m. ( EST ) .
In Article Trend: Neutral
February 28, 2024 (15:15) / "Benzinga" (by Globe Newswire)
Global Cell-Free Protein Expression Market Size is Estimated to Reach USD 450.79 million by 2030, Growing at a CAGR of 8.26%: Straits Research
New York, United States, Feb. 28, 2024 ( GLOBE NEWSWIRE ) -- A cell-free protein expression is an essential tool for molecular biologists in the primary and applied sciences.
In Article Trend: Somewhat-Bullish
February 27, 2024 (14:30) / "Benzinga" (by Benzinga Insights)
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 5 Years - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific TMO has outperformed the market over the past 5 years by 4.18% on an annualized basis producing an average annual return of 16.82%. Currently, Thermo Fisher Scientific has a market capitalization of $214.86 billion.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website